Bronchoalveolar lavage fluid of lung cancer patients: mapping the uncharted waters using proteomics technology. 2011

Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff

The search for proteome-level markers of non-small cell lung cancer (NSCLC) has been mainly limited to serum or cell line screening approaches up to this point. We would like to demonstrate by this proof-of-principle study investigating bronchoalveolar lavage fluid samples from a cohort of NSCLC and control patients, that this readily available biofluid might be a more suitable source for discovering clinically usable NSCLC biomarkers.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D040901 Proteomics The systematic study of the complete complement of proteins (PROTEOME) of organisms. Peptidomics

Related Publications

Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
September 2009, Proteomics. Clinical applications,
Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
February 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
February 2017, Scientific reports,
Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
January 2015, Cancer genomics & proteomics,
Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
March 2020, Expert review of respiratory medicine,
Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
December 1996, American journal of respiratory and critical care medicine,
Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
August 2022, Cancer research,
Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
March 1999, American journal of respiratory and critical care medicine,
Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
June 2017, BBA clinical,
Tonio Oumeraci, and Bernd Schmidt, and Thomas Wolf, and Marc Zapatka, and Andreas Pich, and Benedikt Brors, and Roland Eils, and Michael Fleischhacker, and Brigitte Schlegelberger, and Nils von Neuhoff
September 1994, Cancer,
Copied contents to your clipboard!